×
About 6,111 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  2,759 results

Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by...
https://doi.org/10.1016/j.jid.2021.04.010
The Journal of Investigative Dermatology; Cao Y, Harvey BP et. al.

May 9th, 2021 - Adalimumab (ADA) is the only FDA-approved treatment for moderate-to-severe hidradenitis suppurativa (HS), whereas etanercept (ETN) and certolizumab-pegol (CZP) have been shown to be ineffective, suggesting that the mechanism of action of ADA is di...

Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic revie...
https://doi.org/10.1080/09546634.2021.1927949
The Journal of Dermatological Treatment; Gupta AK, Shear NH et. al.

May 7th, 2021 - We determined the relative efficacy of non-surgical monotherapies for hidradenitis suppurativa (HS). Network meta-analyses were conducted to determine treatments' surface under the cumulative ranking curve (SUCRA) value (i.e., an estimate that ran...

Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Towa...
https://doi.org/10.12788/cutis.0195
Cutis Misitzis A, Katoulis A

May 6th, 2021 - Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Toward Patient-Centered Practice.|2021|Misitzis A,Katoulis A,|

A safety review of biologic therapies for the management of hidradenitis suppurativa an...
https://doi.org/10.1080/14740338.2021.1924147
Expert Opinion on Drug Safety; Holcomb ZE, Porter ML et. al.

Apr 29th, 2021 - Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disorder characterized by nodules, abscesses, fistulae, and significant scarring in intertriginous areas rich in apocrine glands. Immunomodulator drugs, including biologics...

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex; Is It a New Varian...
https://doi.org/10.1177/12034754211010145
Journal of Cutaneous Medicine and Surgery; Fletcher J, Posso-De Los Rios C et. al.

Apr 28th, 2021 - Hidradenitis suppurativa and steatocystoma multiplex may coexist in the same patient. The overlap of these 2 conditions could be suggestive of an unrecognized defect in follicular proliferation mutual in the pathogenesis of both conditions. Here w...

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Clinicaltrials.gov  2,987 results

Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by...
https://doi.org/10.1016/j.jid.2021.04.010
The Journal of Investigative Dermatology; Cao Y, Harvey BP et. al.

May 9th, 2021 - Adalimumab (ADA) is the only FDA-approved treatment for moderate-to-severe hidradenitis suppurativa (HS), whereas etanercept (ETN) and certolizumab-pegol (CZP) have been shown to be ineffective, suggesting that the mechanism of action of ADA is di...

Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic revie...
https://doi.org/10.1080/09546634.2021.1927949
The Journal of Dermatological Treatment; Gupta AK, Shear NH et. al.

May 7th, 2021 - We determined the relative efficacy of non-surgical monotherapies for hidradenitis suppurativa (HS). Network meta-analyses were conducted to determine treatments' surface under the cumulative ranking curve (SUCRA) value (i.e., an estimate that ran...

Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Towa...
https://doi.org/10.12788/cutis.0195
Cutis Misitzis A, Katoulis A

May 6th, 2021 - Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Toward Patient-Centered Practice.|2021|Misitzis A,Katoulis A,|

A safety review of biologic therapies for the management of hidradenitis suppurativa an...
https://doi.org/10.1080/14740338.2021.1924147
Expert Opinion on Drug Safety; Holcomb ZE, Porter ML et. al.

Apr 29th, 2021 - Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disorder characterized by nodules, abscesses, fistulae, and significant scarring in intertriginous areas rich in apocrine glands. Immunomodulator drugs, including biologics...

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex; Is It a New Varian...
https://doi.org/10.1177/12034754211010145
Journal of Cutaneous Medicine and Surgery; Fletcher J, Posso-De Los Rios C et. al.

Apr 28th, 2021 - Hidradenitis suppurativa and steatocystoma multiplex may coexist in the same patient. The overlap of these 2 conditions could be suggestive of an unrecognized defect in follicular proliferation mutual in the pathogenesis of both conditions. Here w...

see more →

News  271 results

Two Studies Add to Knowledge Base of Biosimilar Use in Psoriasis, HS
https://www.medscape.com/viewarticle/950197

Apr 28th, 2021 - A cohort study of psoriasis patients in Denmark found that a nonmedical switch from brand name adalimumab to adalimumab biosimilars was not associated with drug retention at 1 year. And another study, a small, single-center retrospective study of ...

New Analysis Eyes the Surgical Landscape for Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/948026

Mar 23rd, 2021 - Among patients who undergo surgery for hidradenitis suppurativa (HS), wide excision and flap-based reconstruction are associated with lower postsurgical recurrence, yet these options should be balanced against potentially higher morbidity of exten...

Inflammatory Skin Diseases and CKD Risk: What’s the Link?
https://www.medscape.com/viewarticle/947916

Mar 22nd, 2021 - Takeaway Atopic eczema, psoriasis and hidradenitis suppurativa were weakly associated with chronic kidney disease (CKD), independent of obesity, cardiovascular morbidity or non-biologic nephrotoxic skin medications. No evidence supporting this ass...

Adalimumab Enhances Primary Wound Closure After HS Surgery
https://www.medscape.com/viewarticle/945207

Feb 2nd, 2021 - Delaying surgical reconstruction of fistula structures until after patients with hidradenitis suppurativa (HS) have been on adalimumab for a minimum of 6 months transforms primary wound closure into a highly attractive option, a pilot study sugges...

Oral JAK1 Inhibitor Shows Promise for Hidradenitis Suppurativa
https://www.medscape.com/viewarticle/944781

Jan 26th, 2021 - A once-daily oral selective Janus kinase 1 inhibitor demonstrated promising safety and efficacy for the treatment of moderate to severe hidradenitis suppurativa (HS) in a pair of small, randomized, phase 2 studies that established proof-of-concept...

see more →

Patient Education  93 results see all →